Floatz logo

hsp990

Alzheimer's Disease (AD)

Universitaire Ziekenhuizen KU LeuvenN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Alzheimer's Disease (AD) cohort.

Asset / SponsorPhaseRating
Abbv-916
AbbVie
Phase 2B
Abbv-552
AbbVie
Phase 2B
FLORTAUCIPIR
Molecular NeuroImaging
Phase 1CCC
Oxaloacetate
Russell Swerdlow
Phase 1CC
Ckd-355B
Chong Kun Dang Pharmaceutical
Phase 1CC

View all 12 →

Same molecule, other indications

hsp990 is also rated in:

Advanced Solid MalignanciesDormant
CC
Indicative ·
44 / 100
View asset →
cancerDormant
C
Indicative ·
36 / 100
View asset →
Parkinson's Disease (PD)Dormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →